December 3, 2021, Gilead Sciences, Inc. issued a recall on 2 lots of Veklury (remdesivir) that had been found to be contaminated with tiny glass shards.  The earliest date that one of the lot numbers could have reached a distributor is October 25, 2021. The press release can be found here: Gilead Issues a Voluntary Nationwide Recall of Two Lots of Veklury® (Remdesivir) Due to Presence of Glass Particulates